MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

DMHCA

CAS No. : 79066-03-8

MCE 站：DMHCA

产品活性：DMHCA 是一种有效的选择性 LXR 激动剂，特别激活 LXR 通路的胆固醇流出臂，而不刺激甘油三酯的合成。DMHCA 具有抗炎作用，可用于糖尿病胆固醇稳态的研究。

研究领域：Metabolic Enzyme/Protease

作用靶点：LXR

In Vitro: In ex vivo treatment of diabetic CD34⁺?cells, DMHCA (10 ?M; 16-18 hours) restores the fluidity of the membranes to baseline nondiabetic levels.
DMHCA restores the levels of BM-derived TNF-α and IL-3 to baseline and significantly reduces CCL-2 production by >50% in the BM supernatants and the systemic circulation compares to the control mice. DMHCA also increases the number of CACs in the BM and peripheral circulation and upregulates the egression of vascular reparative cells into the peripheral circulation.
In the PAGA analysis, DMHCA treatment enhances the overall production and robustness of erythrocyte progenitors. DMHCA enhances flux down the erythrocyte progenitor lineage. It also DMHCA increase in erythrocyte progenitor density in BM cells. DMHCA not only expands the proportion of erythrocyte progenitors but also increases the expression of the hemoglobin beta adult chain (HBB-BT).

In Vivo: DMHCA (oral administration; 6 months; chow 8mg/kg body weight /day) restores cholesterol homeostasis in diabetic retina. It significantly increases endogenous LXR ligands, desmosterol, and total oxysterols in the diabetic retina.

相关产品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Diabetes Related Compound Library  |  Lipid Compound Library  |  T0901317  |  GSK2033  |  LXR-623  |  27-Hydroxycholesterol  |  (20S)-Protopanaxatriol  |  SR9243  |  SR9238  |  24-Hydroxycholesterol  |  AZ876  |  Saikosaponin A  |  Yamogenin  |  Nagilactone B  |  Gymnestrogenin  |  Iristectorigenin B  |  LXRβ agonist-2

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。